Our studies change frequently. For the most accurate list of current enrolling studies
please e-mail us at email@example.com or call 314-514-8509 to see if you qualify for a study
Study #1 – Participants needed who have been Using a Daily Asthma Maintenance Inhaler for the Past 3 Months
Study #4 – Seeking Adolescents who Struggle to Control their Asthma Despite Daily Treatment
Study #1 Have you been using a daily maintenance inhaler for the past 3 months?
The Clinical Research Center is conducting a research study to evaluate the safety and efficacy of an investigational medication to treat asthma. The study consists of 8-10 visits over 16-18 weeks. You will stay on your current inhalers during the course of the study and the study medication will be added onto your current standard of care.
- You must be 12 years of age or older
- You must be on inhaled corticosteriods consistently for at least 3 months prior to starting the study
- You must be experiencing symptoms despite current treatment
- You must have a diagnosis of Asthma for at least 6 months
- You must not have a diagnosis any other significant respiratory disease
- You must not be a current or former smoker with a pack year history more than 10
The Clinical Research Center is conducting a research study to evaluate the safety and effectiveness of Omalizumab (Xolair) compared with placebo for the treatment of chronic nasal polyps. The study consists of 10-14 visits over approximately 52 weeks. The medication is delivered by injection.
- You must be between the ages of 18 to 75
- You must have moderate to severe nasal polyps on both sides of your nose
- You must be using inhaled nasal steriods to treat your nasal polyps for at least 4 weeks prior to starting the study
- You must not be allergic or have a hypersensitivity to Omalizumab
- You must be experiencing significant symptoms, such as chronic congestion or loss of smell
- You cannot have undergone nasal surgery within the past 6 months
The Clinical Research Center in West St. Louis County is evaluating the effectiveness of an investigational inhaler for asthma. The study consist of 4 visits over approximately 8 week and is placebo-controlled.
- You must be 12-75 years of age or older
- You must have Body Mass Index of less than 40
- You must be diagnosed with asthma for at least six months
- You must be using a daily maintenance inhaler at a stable dose for the past 4 weeks or using a rescue inhaler on a daily basis
- You cannot have a history of life-theatening asthma, including intubation or seizures due to lack of oxygen
- You cannot be a current smoker or a former smoker with a pack year history greater than 10
The Clinical Research Center is conducting a 52 week research study to evaluate the safety and effectiveness of an investigational medication for asthma. The majority of the visits will be scheduled in the evening.
- Participants must be between the ages of 12-17
- Participation requires the legal guardian’s consent
- Participants must be using low dose inhaled corticosteriods in combination with another medication or medium to high dose inhaled corticosteriods alone for the past 3 months
- Participants must be experiencing asthma symptoms despite treatment
- Participants cannot have been intubated for their asthma in the past
- Participants must able to maintain a regular day/night sleep schedule